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Introduction
Transabdominal ultrasound (US), computed tomographic (CT)
scanning and magnetic resonance imaging (MRI) are estab-
lished diagnostic tools for liver diseases. In addition, percuta-
neous interventions, most commonly with US or CT-guidance,
are often used to perform a wide range of liver and biliary inter-
ventional procedures, including: vascular interventions (as
transjugular intrahepatic portosystemic shunt and transjugular
liver biopsy), percutaneous interventions (such as liver biopsy,
collections/abscess drainage and transhepatic biliary interven-
tions, namely percutaneous transhepatic cholangiography and/
or biliary drainage) and interventional oncologic therapeutic
procedures (such as transarterial tumor embolization [hepatic
radioembolization] and tumor ablations using thermal ablation
techniques [radiofrequency ablation]). Despite their wide-
spread use, these techniques have limitations. Endoscopic ul-
trasound (EUS), a first-line investigation method for evaluation
of the mediastinum, esophagus, stomach, pancreas, and biliary
tract, has an expanding role in the field of hepatology comple-
menting the traditional investigational modalities. We aimed to
review the current scientific evidence regarding diagnostic and
therapeutic applications of EUS for hepatic diseases.
Search strategies and criteria
A search was performed in Pubmed with the keywords (liver OR
hepatic) and (EUS OR "endoscopic ultrasound") and (diagnosis
OR diagnostic OR treatment OR therapeutic OR ablation OR in-
tervention). Inclusion criteria were: case reports, series, clinical
studies, studies in animal models and reviews regarding EUS
applications in liver disorders, including portal hypertension.
Reports about the use of EUS in extrahepatic bile duct, gallblad-
der, and other extrahepatic structures were excluded. Non-
English language literature without an English translation was
also excluded. On March 4, 2018, the search yielded 1095 arti-
cles, 201 of which were included in this review.
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ABSTRACT
Background and aim Transabdominal ultrasound (US),
computed tomographic scanning (CT) and magnetic reso-
nance imaging (MRI) are established diagnostic tools for liv-
er diseases. Percutaneous transhepatic cholangiography is
used to perform hepatic interventional procedures includ-
ing biopsy, biliary drainage procedures, and radiofrequency
ablation. Despite their widespread use, these techniques
have limitations. Endoscopic ultrasound (EUS), a tool that
has proven useful for evaluating the mediastinum, esopha-
gus, stomach, pancreas, and biliary tract, has an expanding
role in the field of hepatology complementing the tradition-
al investigational modalities. This review aimed to assess
the current scientific evidence regarding diagnostic and
therapeutic applications of EUS for hepatic diseases.
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Diagnostic role of EUS in liver disease
Technical considerations
To evaluate the liver with EUS, one must first take into account
that its perspective of liver anatomy is much different from US
or CT images and requires three-dimensional conceptualization
of the liver parenchyma. The Couinaud classification [1] is the
most widely used system to describe liver anatomy and divides
the liver into eight (I-VIII) functionally independent units,
termed segments, based on planes through the hepatic veins
(HV) and the bifurcation of the main portal vein (PV) (▶Fig. 1).
With EUS, these liver segments are recognized by identifying
the following structures: (1) PV branches with thick and hyper-
echoic walls, Doppler positive; (2) HV branches (left and mid-
dle) with thin and non-reflective walls, straight course, Doppler
positive; (3) biliary radicals with hyperechoic walls, irregular
course, Doppler negative; (4) ligaments (venosum and teres)
with thick and hyperechoic structures without lumen, extend-
ing between vessels and liver capsule; and (5) surface land-
marks (gallbladder, falciform ligament and liver hilum). The
longitudinal and cross-sectional schematic representations of
linear EUS (▶Fig. 2) through the liver from the proximal stom-
ach with a clockwise probe rotation from A-D (▶Fig. 2a) and
from 1–4 (▶Fig. 2b) must be taken into account.
A step-by-step endosonographic evaluation of the liver is
performed as described by Bhatia et al. [2]. From the stomach,
it is possible to evaluate the left lateral segments (segments II
and III), as well as the umbilical part of the left PV and ligamen-
tum teres (l.t.), the medial segment of the left lobe (segment
IV), ligamentum venosum (l.v.), the caudate lobe (segment I),
the inferior vena cava (IVC), the right lobe (segments V and
VIII) and the liver hilum. From the duodenal bulb, segments VI
and VII, the hepatoduodenal ligament structures and PV and
hepatic artery (HA) branches, the liver hilum and the segmental
divisions of right PV and HA are visualized.
EUS has several potential advantages over other imaging
modalities regarding optimal visualization of the liver: the EUS
transducer can be positioned closely to the liver thereby avoid-
ing interposing structures (such as rib cage, bowel loops, gall-
bladder, pleural space, ascites and a thickened abdominal wall,
which are all well-known limitations of, for example, transab-
dominal ultrasound [3]), and it has the potential to thoroughly
evaluate the left liver lobe, hilum and deeply-located areas of
the liver, such as the caudate lobe. One potential limitation is
the evaluation of the right lobe. It is examined from the duode-
num, which is technically difficult because of the small endoso-
nographic window and is possibly further compounded by the
limited depth of penetration of the ultrasound waves [4].
Doppler ultrasound, through different implementations (as
continuous-wave, pulsed-wave, color and power Doppler), can
be used to identify blood flow in vessels. It is useful for charac-
terizing liver anatomy, identifying interposed vessels during
punctures and evaluating portal hypertension (PHT). Regarding
vascular changes in PHT, EUS-Doppler has a distinct advantage
over endoscopy, as it can reveal not only gastroesophageal vari-
ces, but also collaterals adjacent to or outside the wall such as
periesophageal collateral veins (peri-ECV), paraesophageal col-
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▶ Fig. 1 Liver segments described by Couinaud [1].
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▶ Fig. 2 a Longitudinal and b cross-sectional schematic represen-
tations of linear EUS scans through the liver from the proximal
stomach [2]. MHV, middle hepatic vein; LHV, left hepatic vein; UP,
umbilical part of the left portal vein; Ao, aorta.
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lateral veins (para-ECV) collaterals and perforating veins [5–9].
Moreover, EUS can more accurately determine their size and
wall thickness [10] and assess hemodynamic changes in portal
and azygos veins and left gastric vessels, important parameters
to consider for bleeding management.
Real-time elastography is another helpful tool that provides
color-coded images and semi-quantitative measurements
related to tissue stiffness of liver parenchyma and focal lesions
as an additional tool in determining the etiology of the lesion.
The need for manual tissue pressure required during standard
transabdominal US elastography is overcome by comparing
the ultrasound signals obtained over several seconds of normal
breathing and blood circulation [11]. Also important is that
elastography imaging via EUS is not limited by ascites and thick-
ened abdominal wall [3].
Contrast-Enhancement (CE) is an emerging technique that is
becoming more and more available to improve US and EUS di-
agnostic performance of focal liver lesions. CE-EUS is categor-
ized into two types: CE-EUS with the Doppler method (CE-EUS-
D) and CE-EUS with harmonic imaging (CE-EUS-H). CE-EUS-D
helps distinguishing between vascular-rich and hypovascular
areas of a target lesion. CE-EUS-H provides a more detailed vas-
culature image of the target lesion. Both modes can be obtain-
ed to characterize a target lesion, and can be used depending
on the purpose. Few US contrast agents are available world-
wide, Sonovue and Sonazoid being the most widely used. These
are made of microbubbles with a shell of phospholipids that are
filled with sulfur hexafluoride gas. Since they are confined to
the vessels after injection, it allows visualization of the tiny ves-
sels in the capillary bed and therefore dynamic detection of ca-
pillary microvascularization. Given the dual blood supply of the
liver, from the portal vein and the hepatic artery, three vascular
phases can be observed with this ultrasound contrast: the ar-
terial phase, beginning within 20 seconds after the injection
and continuing for 30 to 45 seconds; the portal venous phase,
that lasts up to 120 seconds; and then the late phase which per-
sists until clearance of the US contrast agent from the circula-
tion (usually 6 minutes). CE-EUS has several advantages over
CT and MRI [12]: (1) It is performed in real time; (2) The con-
trast is not excreted by the kidneys, thus it does not need pre-
investigational renal function testing and it can be used in pa-
tients with renal insufficiency, where contrast-enhanced CT or
contrast-enhanced MRI are contraindicated; (3) Confinement
in the vascular space without extravasation into the interstitial
fluid allows a prolonged enhancement of the vascular system
and the evaluation in the different vascular phases previously
described; (4) It has a much higher resolution compared to
other imaging modalities, enabling full study of the enhance-
ment dynamics of lesions; and (5) It has an excellent tolerance
and safety profile that makes it appropriate for repeated follow-
up examinations.
EUS guided-liver biopsy (EUS-LB) may be safer than its per-
cutaneous counterpart for performing hepatic tissue sampling
in patients with coagulation disorders, such as those with liver
cirrhosis [13, 14]. The 19-gauge biopsy needle, which is smaller
than the 16-gauge needles traditionally used in transcutaneous
LB, can be oriented under direct vision into the liver for sam-
pling avoiding puncturing larger vessels [15]. Abdominal skin
surgical scars, ascites or dense abdominal wall thickness are
also not limitations. Few studies compared the yield of percuta-
neous versus EUS-guided liver sampling, concluding that speci-
men adequacy and diagnostic yield are at least comparable be-
tween both techniques, ranging from 90% to 100% [16]. Re-
cently, a comparison between “blind” liver biopsies using dif-
ferent commercially available 19-gauge needles (Cook Echotip
Procore, Olympus EZ Shot 2, Boston Scientific Expect Slimline,
Covidien SharkCore) was performed and the Covidien Shark-
core needle produced statistically superior histological speci-
men by capturing more complete portal tracts, possible due to
its design [17].
Focal liver lesions
EUS is a useful adjuvant to CT and MRI in diagnosing and char-
acterizing focal liver lesions (FLL) [18, 19]. Several studies [4,
20–22] have showed superiority of EUS over CT in detecting
FLL, especially when they are small (< 1 cm) or located in the
left lobe or hilum. Awad et al. showed that EUS could diagnose
additional hepatic lesions in 28% of patients with a history of
known liver mass that were detected initially by CT [20].
Aside from detection, EUS may differentiate the etiology of
these lesions using several tools.
First, a validated EUS scoring system has been developed,
with a positive predictive value of 88% [23]. With this system,
the presence or absence of certain criteria increases the accura-
cy to differentiate between malignant, benign or indeterminate
FLL. Benign solid FLL are distinct hyperechoic and/or have a dis-
tinct geographic shape, while malignant lesions must have at
least three of the following characteristics: two components
(with isoechoic/slightly hyperechoic center or without isoecho-
ic/slightly hyperechoic center), post-acoustic enhancement,
adjacent structures distortion, hypoechogenicity (slightly or
distinctly) and/or at least 10mm.
Second, EUS-elastography has been described in two studies
[24, 25] as a valuable tool in detecting, characterizing and dif-
ferentiating between benign and malignant FLL with sensitivity,
specificity and diagnostic accuracy of 92.5%, 88.8% and 88.6%,
respectively. More high-quality data are needed to confirm the
potential of EUS-elastography in this field.
Third, differentiation between different types of FLL can also
be studied through vascular enhancement patterns with CE-
EUS, as is also done with CE-US [26] (▶Fig. 3). Typical enhance-
ment patterns are arterial hyperenhancement with subsequent
slow washout in late-phase contrast in hepatocellular carcino-
ma (HCC), arterial hyperenhancement with rim-like enhance-
ment and subsequent rapid washout in metastatic liver cancer
[27] (▶Fig.4), peripheral nodular hyperenhancement, with
centripetal progressive fill-in in hemangioma, and arterial hy-
perenhancement with progressive, centrifugal complete, early,
spoke-wheel arteries, unenhanced central scar in focal nodular
hyperplasia [28].
Moreover, CE-US recently has been considered a useful tool
for evaluating the effects of treatment of HCC. It can dynami-
cally observe tumor vessel perfusion with superior diagnostic
performance for residual tumors after transarterial chemoem-
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bolization (TACE) compared to CE-CT (sensitivity and accuracy
of detecting residual tumor with CE-US 95.6% and 96.2% versus
CE-CT 76.2% and 77.7%, respectively) [29]. For this particular
indication, CE-EUS could be of value, with the advantage of bet-
ter examining the deeper liver lesions not visualized with CE-US
[30]. However, this needs further confirmation.
In addition to the tools described above, EUS-guided tissue
sampling can confirm a HCC diagnosis and avoid unnecessary
surgery [22, 31–48] (▶Fig. 5).
Currently, EUS-guided sampling is indicated “if the patho-
logical result is likely to affect patient management and the le-
sion is poorly accessible/not detected at percutaneous imaging
or a sample obtained via the percutaneous route repeatedly
yielded an inconclusive result” [15]. If cytohistopathological re-
sults are inconclusive, KRAS mutation can be analyzed as it pro-
vides high diagnostic yield in EUS-guided histopathological
evaluation [49]. To reduce the number of needle passes and po-
tential adverse events (AEs), novel ancillary techniques are
being developed. A recent study [50] conducted in animal
models demonstrated technical feasibility of in vivo cytological
observation using a high-resolution microendoscopy (HRME)
system under EUS guidance. The authors concluded that HRME
could obtain clear images representing cytology-level morphol-
ogy of liver and would therefore improve diagnostic accuracy of
EUS-FNA for liver lesions. EUS-FNA may also play a significant
role in staging HCC in patients with cirrhosis with PV thrombus
by differentiating a tumor thrombus from a clot, as its etiology
is difficult to assess in the absence of characteristic hallmarks
[51–55]. This is of paramount importance in HCC manage-
ment, as patients with tumor invasion into the PV are deemed
to have unresectable disease and to be ineligible for transplant
[56]. EUS-FNA of splenic vein thrombus has also been per-
formed to clarify its etiology (benign versus malignant) [57]. A
systematic review concerning complications related to EUS-
guided sampling showed a 2.33% rate of morbidity (bleeding,
infection, pain, fever) and 0.29% rate of mortality (due to un-
controllable cholangitis) after 344 EUS-FNA of hepatic lesions
[58]. Due to the long path required to reach the liver capsule
and the fact that HCC is more vascular in comparison with other
cancers (for example, pancreatic), one could presume a higher
risk of tumor spillage into the peritoneal cavity along the nee-
dle track. Nonetheless, no such cases have been reported so far.
Lastly, convex EUS-Doppler can provide staging information
regarding vascular invasion at the hepatic hilum, an important
parameter to evaluate in, for example, peri-hilar cholangiocar-
cinomas [59].
Liver cirrhosis
Detection of liver fibrosis has important management and
prognostic implications. Traditionally, liver biopsy is considered
the “gold standard” diagnostic method for identifying liver cir-
rhosis, but has drawbacks regarding sampling errors, inter-ob-
server variability and complications [60]. Noninvasive fibrosis
markers, such as liver stiffness measurements (transient elasto-
graphy– Fibroscan– and real-time elastography), have been de-
veloped to overcome these problems. Nonetheless, applicabil-
ity of these measurements with a transabdominal approach is
lower in cases of obesity or ascites and in discriminating be-
tween intermediate stages of fibrosis [60]. In addition, real-
time elastography, used in EUS, can be advantageous over
transabdominal Fibroscan, as it can estimate liver stiffness in
all patients (either obese or not) and has the potential to differ-
entiate between fibrosis and steatosis, as liver steatosis has a
distinct appearance on real-time sono-elastography images,
with low mean hue histogram values [61]. Further studies are
needed, however, to confirm these hypotheses.
▶ Fig. 4 CE-EUS in liver metastases, with arterial hyperenhance-
ment with rim-like enhancement.
▶ Fig. 5 EUS-guided tissue sampling of a hepatic malignant lesion.
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▶ Fig. 3 Typical enhancement patterns of FLL with contrast-en-
hanced ultrasound.
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If histological confirmation is needed, EUS-guided LB is a
safe technique with a diagnostic yield for liver parenchymal dis-
orders such as liver cirrhosis, primary sclerosing cholangitis, au-
toimmune hepatitis and NAFLD between 91% and 100% [62–
73], which is at least comparable to percutaneous or transjugu-
lar routes [16, 74, 75]. Few complications have been reported
with this technique. Four self-limited pericapsular hematomas
[72–74], two cases of duodenal perforations [23], one self-lim-
ited bleeding [62] and a case of a near-fatal hemorrhagic shock
after EUS-LB [76] have been reported so far. Data on patient
preference regarding being submitted to a percutaneous ver-
sus EUS liver biopsy are missing.
Portal hypertension
Detecting vascular changes within and outside of the upper
digestive wall
EUS-Doppler has a higher sensitivity for detecting esophageal
and gastric varices compared to upper endoscopy [5, 77–85]
(▶Fig. 6).
It is also a useful modality for evaluating ectopic duodenal
varices [86–90]. The higher the grade of esophageal varices,
the higher the EUS sensitivity [82]. Success in visualizing small
esophageal varices by EUS can be improved by using small wa-
ter-filled balloons [77], small 20-Hz ultrasound transducers
[91, 92], videotaped high-resolution endoluminal sonography
[81] or high-frequency ultrasound miniature probes [93].
EUS-doppler can diagnose collateral veins, which are found
adjacent to or outside the esophageal wall in patients with
esophageal varices [5–9]. There is a correlation between grade
of esophageal varices and development and diameter of para-
ECV [5] and between diameter of the splenic vein and diameter
of these collaterals [94].
EUS-Doppler can also substantiate diagnosis of portal gas-
tropathy, showing diffuse thickening of the gastric wall with di-
lated paragastric veins [6, 95], thereby distinguishing it from
watermelon stomach, which is characterized by focal swelling
and spongy appearance in mucosa and submucosa [96, 97]. It
is also valuable in differential diagnosis of giant gastric folds
[98, 99], distinguishing benign causes, such as gastric varices,
from malignant causes.
Dynamic assessment of hemodynamic changes
The hepatic venous portal pressure gradient or portal pressure
gradient (PPG) reflects the degree of PHT and is the single best
prognostic indicator in liver disease. Currently, PPG measure-
ment via right jugular vein access is considered the gold stand-
ard. Nonetheless, this is an indirect invasive measurement be-
cause it relies on a wedge pressure to assess portal vein pres-
sure, and may not always accurately reproduce true PV pres-
sures. EUS-guided PV catheterization was developed to over-
come drawbacks of the transjugular approach. It was first per-
formed in porcine models [100–105], appearing feasible and
safe for portal pressure measurements as well as for portal an-
giography and pressure measurements. The first human clinical
report was made by Fuji-Lau et al. [106]. Later, a human study
[106, 107] involving 28 patients demonstrated a 100% techni-
cal success and no AEs in measuring the PPG with a linear
echoendoscope, a 25G FNA-needle and a compact manometer.
An excellent correlation was found between PPG measurement,
clinical evidence of PHT, and clinical suspicion of liver cirrhosis.
Larger clinical trials and comparative studies between both ap-
proaches are needed to confirm and establish the role of this
technique.
Prediction of variceal bleeding and rebleeding
Elevated intravariceal pressure is associated with risk of variceal
bleeding. In 1999, Jackson et al. developed a technique for di-
rectly measuring esophageal variceal wall tension using an ul-
trasonographic transducer and needle puncture of the varix
[108]. Later, to avoid risk of variceal bleeding from needle
puncture, Miller et al. [109, 110] developed a noninvasive EUS-
based device by which they successfully measured intravariceal
pressure in a varix model by placing a 20-MHz ultrasound trans-
ducer in a latex balloon catheter sheath and attaching the cath-
eter to a pressure transducer. Another indirect measurement of
intravariceal pressure has been developed using EUS-Doppler-
guided manometry of esophageal varices, using a linear EUS
▶ Fig. 6 Fundus varices in EUS a without Doppler and b with EUS-Doppler.
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probe with power Doppler to assess flow in the varices and a
manometry balloon attached to the tip of the probe [111].
Nonetheless, despite being promising, none of these methods
are in widespread use today.
Other EUS predictors have also been found in relation to risk
of variceal bleeding. Hematocystic spots on the surface of
esophageal varices, identified in EUS as saccular aneurysms,
are closely associated with high risk of variceal rupture [81,
112]. By summing the cross-sectional surface area of all esoph-
ageal varices in the distal esophagus with digitized image, EUS
can predict the risk of variceal bleeding: for each 1 cm2 increase
in variceal cross-sectional surface area (CSA) the risk of variceal
bleeding increases 76-fold per year [113]. Using a cutoff value
for the CSA of 0.45 cm2, sensitivity and specificity for future
variceal bleeding above and below this point are 83% and 75%,
respectively [113]. Furthermore, high blood flow variceal velo-
cities and thin gastric variceal wall (mean thickness of the gas-
tric wall of 1.2 ±0.2mm) correlate with greater bleeding risk
[114]. Number and size of para and peri-ECV [115, 116] and
perforating veins [117, 118] are also associated with risk of var-
iceal bleeding.
EUS has a predictive value identifying rebleeding risk from
esophageal varices by evaluating the type and grade of esoph-
ageal collaterals and cardiovascular structures [80, 119,120].
Collateral vessels in the vicinity of gastric cardia improve after
endoscopic variceal ligation (EVL), indicating that esophageal
varices can be treated by EVL even though they connect with
cardia varices. Their disappearance is associated with longer
periods free from recurrence of esophageal varices [121]. Pa-
tients with peri-ECV and perforator veins [77, 115, 122–124]
and/or with large para-ECV [83, 116, 125–128] are more likely
to experience variceal recurrence and rebleeding. EUS can
clearly predict recurrence of esophageal varices following EVL
with a sensitivity and specificity of 89.2% and 90.5%, respec-
tively [124].
Paraesophageal diameter after EVL is a better recurrence
predictor, because it has a lower cut-off parameter, higher sen-
sitivity, and higher area under a ROC Curve (AUROC) (4mm,
70.6% sensitivity, 84.6% specificity, 0.801 AUROC) [127]. A
study using balloon-occluded retrograde transvenous oblitera-
tion for management of gastric varices concluded that pres-
ence of esophageal varices and high gastric variceal resistance
index assessed by EUS (≥0.24) before the procedure were sig-
nificant risk factors for worsening of esophageal varices after
obliteration [129]. Velocity of hepatofugal blood flow in the
left gastric vein trunk can be determined, and also the branch-
ing pattern, both of which are associated with variceal recur-
rence after endoscopic treatments (anterior branch dominance
and flow velocity of 12 c/s or more are associated with higher
variceal recurrence) [118, 124, 130, 131].
Assessment of pharmacological effects
Variceal rupture results from increased variceal wall tension,
which according to Laplace’s law, is determined by transmural
pressure difference, size and wall variceal thickness. Based on
this formula, few studies have shown that EUS morphological
assessment of varices (column radius and volume) combined
with simultaneous pressure measurement are objective and
useful tools for risk stratification [132, 133]. The effects of so-
matostatin, octreotide, and terlipressin on azygos blood flow
in patients with portal hypertension have also been well eval-
uated by EUS. EUS is capable of documenting a marked de-
crease of the azygos blood flow after injection of vasoactive
agents, showing a potential role for monitoring pharmacologi-
cal effects on the superior porto-systemic collateral circulation
and portal venous flow in patients with portal hypertension
[134–136].
In sum, there are several potential clinical applications of
EUS in portal hypertension, namely in the evaluation of vascular
changes of the digestive wall (through evaluation of esopha-
geal and gastric varices, collateral veins and portal gastropa-
thy), dynamic assessment of hemodynamic changes (through
EUS-guided PV catheterization), prediction of variceal bleeding
and rebleeding (through intravariceal pressure measurements,
evaluation of hematocystic spots, summing the cross-sectional
surface area of EV, calculation of type and grade of collateral
veins) and assessment of pharmacological effects. Nonethe-
less, despite the multiplicity of possible uses, EUS currently
does not have an established role in clinical practice to explore
portal hypertension. More efficacy and safety data are needed.
Therapeutic role of EUS
EUS-guided liver tumor ablation/injection
Several EUS-guided liver tumor ablation/injection techniques
have been described in the literature.
Radiofrequency ablation (RFA) is an alternative low-risk
minimally invasive therapy for HCC and liver metastases when
resection cannot be performed or, in case of HCC, when trans-
plantation cannot be executed [137]. EUS-guided RFA with a
prototype retractable umbrella-shaped electrode array has
been created for effective coagulation necrosis of large areas,
minimizing the risk of gastric mucosa damage [138]. More re-
cently, a monopolar RFA under EUS guidance using a 1-Fr wire
electrode (Habib) was introduced and tested in pig models
[139, 140]. Its flexible and thinner electrode could facilitate tis-
sue access. Although one study did not show definite coagula-
tive necrosis in the liver [139], another study did show positive
results [140]. Further studies are needed to fully examine the
response of tumor tissues to EUS-RFA.
Cryothermy (Cool-Tipped RFA) is a new flexible ablation de-
vice with a hybrid cryotherm probe that combines bipolar RFA
with cryotechnology allowing for more efficient tissue ablation
in the setting of lower temperatures provided by the cooling
cryogenic gas [141]. In a single study, EUS-guided transgastric
cryotherm ablation in porcine liver resulted in well-defined ab-
lation areas without any complications [142].
Neodymium:yttium-aluminum-garnet (Nd-YAG) laser abla-
tion is a minimally invasive method for solid tumor destruction
by directing low-power laser light energy into tissue. Its advan-
tages are use of thinner needles, shorter application time and
the ability to reuse and re-sharpe the needle, which can be
used at different angles. Di Matteo et al. [143] reported the
first human case of EUS-guided Nd:YAG laser ablation for treat-
Campos Sara et al. The role of… Endoscopy International Open 2019; 07: E1262–E1275 E1267
ment of HCC located in the caudate lobe, with favorable prog-
nosis. More recently, a prospective study including 10 patients
with HCC or liver metastasis from colorectal carcinoma conclu-
ded that EUS-guided laser ablation might be technically feasi-
ble in selected tumors of the caudate lobe and left liver [144].
Nonetheless, the safety of this modality must be further con-
firmed in future studies.
High-intensity focused ultrasound (HIFU) was first devel-
oped as a thermal ablation method to ablate prostatic tissue
and later to ablate liver metastases surgically or via a transcuta-
neous approach. Recently, a EUS-HIFU device has been created
with the aim of treating tumors localized near the gastric lumen
without the difficulties of gas interposition. Two reports, per-
formed in living pig models, achieved complete necrosis of the
lesions and had no immediate AEs [145, 146].
EUS-guided fine-needle ethanol injection was developed to
deliver therapeutic agents to a target site more precisely and
minimize damage to non-tumor tissue compared to the percu-
taneous approach. The efficacy and safety seen in the case re-
ports and case series of EUS-guided ethanol injection in HCC
[147–150] and hepatic metastasis [151, 152] suggest a pro-
mising role for EUS in managing lesions that are difficult to ac-
cess with conventional methods. After EUS-guided ethanol liver
tumor injection, a self-limited subcapsular hematoma [152]
was reported.
EUS-guided iodine-125 brachytherapy is another palliative
treatment. Although usually performed percutaneously, EUS-
guided iodine-125 brachytherapy can be a safe and effective al-
ternative for left-sided liver tumors refractory to transabdomin-
al interventions [150].
EUS-guided portal injection chemotherapy (EPIC) using iri-
notecan-loaded microbeads in liver metastases can increase in-
trahepatic irinotecan concentrations while decreasing systemic
exposure [153].
EUS-guided fiducial placement for stereotactic body
radiation therapy
Use of EUS-guided fiducial placement for stereotactic body ra-
diation therapy (SBRT) is becoming more widespread. Using
multiple photon beams that intersect at a stereotactically de-
termined target, it delivers higher doses of radiation into the
tumor while sparing surrounding normal tissue. As the liver is
very radiosensitive, accurate targeting of the tumor while sal-
vaging normal hepatic parenchyma is crucial to prevent radia-
tion-induced liver injury. SBRT requires implantation of fiducial
markers in the lesion for adequate detection. EUS-guided fidu-
cial placement seems to be a safe and technically feasible tech-
nique for preparing patients with deeper liver malignancies for
SBRT that are not feasible for percutaneous approaches [154,
155].
EUS-guided selective portal vein embolization
Preoperative embolization of PV branches causing atrophy of
the hepatic segments to be removed and subsequent compen-
satory hypertrophy of the remaining segments has proven to be
safe and effective in patients undergoing extensive hepatect-
omy [156, 157]. Matthes et al. [158] reported the first success-
ful EUS-guided selective PV embolization with Enteryx (ethy-
lene-vinyl alcohol copolymer) in a single swine model.
EUS-guided cyst ablation
Most simple liver cysts require no treatment. However, when
they become symptomatic, treatment is indicated. Surgery is
the classical approach, but as it leads to considerable morbidity
rates, other less-invasive modalities were developed. Percuta-
neous aspiration (US or CT-guided) with lavage therapy with a
sclerosing agent has demonstrated encouraging results with
minimal AEs. More recently, EUS-guided aspiration and lavage
therapy with alcohol has been postulated as having the advan-
tage of not requiring insertion of a percutaneous drainage
catheter, thus enabling alcohol lavage to be done with a one-
step approach and has been considered a preferred approach
to left lobe cysts [159]. There is a newer sclerosing agent used
in EUS-FNA (1% lauromacrogol) that seems to have fewer side
effects than traditional ethanol and can thus be used as a repla-
cement [160].
EUS-guided liver abscess drainage
Percutaneous drainage (PCD) is a first-line method for liver ab-
scess drainage because of its minimal invasiveness and high
technical success rate [161, 162]. However, it has several disad-
vantages, such as external-drainage and self-tube removal that
may lead to patient discomfort. Recently, EUS-guided liver ab-
scess drainage (EUS-AD) has been developed with the advanta-
ges of doing one-step internal drainage (which has an obvious
cosmetic benefit and avoids risk of self-tube removal and peri-
tonitis). Nonetheless, only a few cases have been reported
[163–173]. Even fewer reports can be found on EUS-ADusing
fully-covered self-expandable metallic stents (fcSEMS) [168–
172, 174]. SEMS are expandable and have a larger diameter
compared to plastic stents, resulting in impaction between the
stent and the surrounding drainage area or abscess wall, and
thus potentially less leakage into the abdominal cavity. In addi-
tion, the larger diameter allows for a better drainage effect, ob-
viating the need for multiple sessions to clean the abscess and a
lesser procedure time. If, however, a direct endoscopic necro-
sectomy is indicated, it can be easily performed through the
large-bore stent. Finally, SEMS can also be helpful in hemostasis
when unexpected bleeding from the tract occurs during the
procedure. Ogura et al. [172] concluded that EUS-ADwith
fcSEMS is a potential first-line treatment for liver abscesses,
particularly in the left liver lobe, as it is associated with shorter
hospital stay, higher clinical success and lower AE rates compar-
ed to PCD. So far, only one case report has described a success-
ful EUS-ADof the right hepatic lobe with SEMS [175].
Infected hepatic cysts are much rarer and only a single case
has reported an effective EUS-guided drainage [176]. Rare in-
fected intracystic papillary hepatic adenocarcinomas have also
been successfully approached by EUS [177].
EUS-guided therapy for portal hypertension
Apart from improving the diagnosis, EUS can also assist in the
management of PHT.
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Nagamine et al. [178] conducted a successful pilot study of a
“modified” esophageal variceal ligation (EVL) technique using
an EUS-color Doppler with the aim of decreasing variceal recur-
rence rate associated with traditional EVL. As it has been shown
that persistence of patent varices, perforating veins or peri-ECV
are associated with variceal recurrence, EVL performed with
EUS can be advantageous compared to upper endoscopy as it
can better identify these zones and assist in completing variceal
eradication.
Esophageal varices can also be eradicated using EUS-guided
sclerotherapy, as concluded in a randomized controlled study
by Paulo et al. [179]. This procedure seems to reduce recur-
rence of esophageal varices after endoscopic therapy [180]
and the azygus vein diameter [181]. Minor complications in
EUS-sclerotherapy (as thoracic pain and self-limited bleeding)
have been reported and do not seem to differ from the endo-
scopically induced complications [179].
For eradication of gastric varices, EUS-guided cyanoacrylate
injection with/without coiling with precise injection in the col-
laterals veins can be valuable, both for obtaining hemostasis
during active bleeding and in primary and secondary bleeding
prophylaxis [182–191] (▶Fig. 7).
EUS-guided cyanoacrylate injection with/without coiling has
been also used for duodenal varices [86, 87, 192]. EUS can fur-
ther be useful for evaluating adequacy of tissue adhesive in var-
iceal obturation [193]. EUS-guided cyanoacrylate injection has
been associated with fever, chest pain, post-injection ulcers,
and asymptomatic pulmonary glue embolisms [182]. These
AEs, however, seem to be fewer than with endoscopy-guided
injection [186].
EUS-guided coiling is another option for embolization of
gastric varices [194]. It requires fewer procedures and has few-
er AEs than EUS-guided cyanoacrylate injection although larger
comparative studies are needed [182]. One coil migration into
the liver was described, but passed spontaneously retrograde
into the portal vein and assumed a final position in the subcap-
sular liver without clinical sequelae [195] and few cases of self-
limited bleeding have occurred at the puncture site during the
procedure [196]. AEs associated with EUS-guided coil applica-
tion tend to be fewer than with EUS-guided cyanoacrylate in-
jection [182]. Combining cyanoacrylate injection and coil em-
bolization showed favorable results in large studies [183, 197].
Combining both carries a 7% AE rate (self-limited abdominal
pain, pulmonary embolization, and bleeding) [187]. Good
short-term outcomes after microcoil injection in anastomotic
varices after total pancreatectomy have also been reported
[196].
A case report of small bowel variceal bleeding demonstrated
successful management using an EUS-assisted human throm-
bin injection [198].
▶ Fig. 7 EUS-guided cyanoacrylate in varices. a EUS-doppler evaluation of varices. b EUS-puncture of the varix. c EUS-guided cyanoacrylate.
d Varix total obliteration with the cyanoacrylate.
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Finally, traditional transjugular intrahepatic portosystemic
shunt (TIPSS), an effective treatment for PHT complications,
can be technically challenging when performed in the setting
of IVC and HV obstruction. In addition, catheter manipulation
through the right atrium and intrathoracic IVC may be danger-
ous in patients with severe cardiopulmonary disease. EUS-guid-
ed IPSS creation [103, 199–201] was thus introduced as a po-
tentially advantageous alternative as it does not require en-
trance into the heart or the IVC and decreases radiation expo-
sure to both patient and physician during stent deployment.
Also, it could become a valid therapeutic option in patients
with active variceal bleeding that does not respond to endo-
scopic hemostasis and who are not stable enough to sustain
transport to a radiology suite or when there is an anticipated
delay before conventional TIPSS placement.
Limitations of EUS
The potential drawback of EUS when used for diagnostic purpo-
ses might be that it is invasive and expensive to perform. In ad-
dition, as already described, diagnostic accuracy is limited for
lesions located in the right liver lobe or under the dome of the
diaphragm. Presence of fatty infiltration, calcifications, pneu-
mobilia, and extensive fibrosis may also interfere with ultra-
sound images. Altered anatomy (for example, presence of a
pharyngeal diverticulum or a tight stricture), as is an upper gas-
trointestinal endoscopy, may also restrict EUS performance.
Some of the EUS tools discussed here may also be unavailable.
The endosonographer’s experience and diligence by which the
liver is scrutinized are of critical diagnostic and therapeutic im-
portance.
Patients included in the studies either had no cirrhosis or a
compensated cirrhosis. To fully evaluate use of EUS interven-
tions, it would be very interesting to incorporate patients with
decompensated cirrhosis in the study population, as they are
susceptible to higher rates of complications such as bleeding/
infection.
A clear limitation of the current literature of EUS related to
liver diseases is that the majority of the studies have been
small, single-center, often retrospective and non-randomized.
Experience with EUS interventional procedures in the liver re-
mains limited mainly to animal feasibility studies and small hu-
man case series.
Therefore, although promising, much work needs to be
done to firmly and scientifically establish the indication of diag-
nostic and therapeutic EUS in liver disease, including resolving
issues pertaining its cost-effectiveness.
Conclusion
EUS has potentially significant clinical applications in diagnosis
and treatment of liver disorders. It provides excellent, unob-
structed, real-time imaging of the liver at high resolution. Ad-
junct tools such as Doppler, elastography, and contrast can be
used to improve its diagnostic yield. EUS-guided interventional
procedures to measure portal hepatic pressure, ablate hepatic
tumors and cysts, and drain liver abscesses have great potential
to be patient friendly, cost-effective treatment alternatives
with limited risk of complications. It should also be recognized
that EUS is limited in regard to right lobe access. All this poten-
tial calls for adequately designed, preferably randomized con-
trolled studies to substantiate the promise of the technology
and firmly establish the role of EUS in diagnostic and therapeu-
tic algorithms for liver disorders.
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